Kathy Wolski is a Preventive Cardiology affiliated with Cleveland Clinic.
Kathy Wolski's published research covers Atherosclerosis Progression and Regression, Cardiovascular Effects of Antidiabetic Therapies, Lipid-Modifying Therapies in Heart Disease, Metabolic Surgery Outcomes in Cardiovascular Risk, and Antiplatelet Therapy in Acute Myocardial Infarction. These are the areas where Synapse's enriched corpus most frequently indexes their work.
Kathy Wolski is a Lead Biostatistician at the Cleveland Clinic's Heart, Vascular and Thoracic Institute. She specializes in statistical analysis for clinical trials in cardiovascular medicine, including studies on diabetes treatments, lipid management, and atherosclerosis. Her research has been published in numerous medical journals and involves collaborations on topics like bariatric surgery and cardiovascular outcomes.
Held affiliations with Cleveland Clinic (2000-2025); Center for Clinical Research (United States) (2012-2024); Michael E. DeBakey VA Medical Center (2023); Johns Hopkins University (2023).
Across their career Synapse has indexed 174 publications, 24,839 citations, h-index 57. Enriched entries for each paper include structured clinical evidence (PICO), methodology classification with level of evidence, and guideline-recommendation linkage where applicable.
Training: MPH at Yale University (1995); B.S. at University of Massachusetts, Amherst (1991).
For the full publication history and per-paper clinical evidence enrichment, see this page on Synapse.
Deterministic synthesis from Synapse's enriched records — 195 words.